I concur whole heartedly. Unfortunately, the horse might have gotten ahead of the cart with LTC: I'm convinced, if only because it makes business sense, that DR started lining up production and professional salaries because he felt that FDA approval was imminent. Why else would you take on that level of commitment with no cash in-flow on the horizon? And the wording in the previous 10K, "expect," indicates a perturbed tone that the proceedings have taken this long.
I grant you that the PRs aren't very compelling and exciting. But let's get serious: any small amount of DD will show not only that the CO2 seperater didn't happen as forecast, but that the company submitted an application for FDA approval in Aug. 07...and of course, it hasn't yet happened. How much excitement and cash can you expect to generate under these circumstances? The OTC especially is packed with billion dollar ideas, the vast majority of which will never survive. This is why I emphasized in a previous post the HUGE amount riding on FDA approval.
Maybe it would be better to issue shares now, at the current PPS because if approval is delayed beyond Q2, we may, as you point out, trade to the right of the decimal point again.
Clearly we're all frustrated by the waiting game. But I think that's our destiny for the near term. Well written or not, there's been very little movement after the last few PRs about Ukrainian Engineers and the Vet subsidiaries, etc. I'm actually very surprised that the PPS has held up this well. Low volume days in a 10 cent range look pretty good to me about now. There's only one PR I want to read when I check my computer, but I'll know it's there before I read it because I check the ticker for CTGI first!
